de Win MM - Search Results

1

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.

de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. de Win MM, et al. Psychopharmacology (Berl). 2004 May;173(3-4):376-82. doi: 10.1007/s00213-003-1723-4. Epub 2004 Jan 15. Psychopharmacology (Berl). 2004. PMID: 14726997

2

Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible.

Booij J, de Bruin K, de Win MM, Lavini C, den Heeten GJ, Habraken JB. Booij J, et al. Among authors: de bruin k, de win mm. Nucl Med Biol. 2003 Aug;30(6):643-9. doi: 10.1016/s0969-8051(03)00046-5. Nucl Med Biol. 2003. PMID: 12900290

3

Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.

de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. de Win MM, et al. Among authors: de jeu ra, de bruin k. Eur Neuropsychopharmacol. 2004 May;14(3):185-9. doi: 10.1016/S0924-977X(03)00101-9. Eur Neuropsychopharmacol. 2004. PMID: 15056477

4

Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.

de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. de Win MM, et al. Neuropsychopharmacology. 2005 May;30(5):996-1005. doi: 10.1038/sj.npp.1300683. Neuropsychopharmacology. 2005. PMID: 15770240 Clinical Trial.

5

The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. De Win MM, et al. Int J Methods Psychiatr Res. 2005;14(4):167-85. doi: 10.1002/mpr.6. Int J Methods Psychiatr Res. 2005. PMID: 16395871 Free PMC article.

6

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Reneman L, et al. Among authors: de win mm. J Psychopharmacol. 2006 Mar;20(2):164-75. doi: 10.1177/0269881106061515. J Psychopharmacol. 2006. PMID: 16510475 Review.

7

Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.

de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. de Win MM, et al. J Psychopharmacol. 2006 Mar;20(2):226-35. doi: 10.1177/0269881106063275. J Psychopharmacol. 2006. PMID: 16510480

8

Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.

Booij J, de Win MM. Booij J, et al. Among authors: de win mm. Nucl Med Biol. 2006 Feb;33(2):185-91. doi: 10.1016/j.nucmedbio.2005.10.005. Nucl Med Biol. 2006. PMID: 16546672 Clinical Trial.

9

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Reneman L, et al. Among authors: de win mm. J Psychopharmacol. 2006 May;20(3):389-99. doi: 10.1177/0269881106063266. J Psychopharmacol. 2006. PMID: 16574713

10

The COMT val158met polymorphism and brain morphometry in healthy young adults.

Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D. Zinkstok J, et al. Neurosci Lett. 2006 Sep 11;405(1-2):34-9. doi: 10.1016/j.neulet.2006.06.034. Epub 2006 Jul 18. Neurosci Lett. 2006. PMID: 16857316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters